Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

162 mg of Aspirin for Prevention of Preeclampsia

NCT05221164 is registered in ClinicalTrials.gov with Methodist Medical Center of Illinois as lead sponsor.

NCT NCT05221164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05221164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
162 mg of Aspirin for Prevention of Preeclampsia
Lead sponsor
Methodist Medical Center of Illinois
Phase
Phase 4
Overall status
Unknown status
Start date
July 6, 2021
Completion date
June 9, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia